The Scottish Medicines Consortium (SMC) has approved AstraZeneca‘s triple combination therapy Trixeo Aerosphere as a maintenance treatment for chronic obstructive pulmonary disease (COPD). The approval specifically covers adults with moderate to severe disease who are not adequately treated by a combination of an inhaled corticosteroid (ICS) and a…
News
As part of its Catalyst Grant program, the American Lung Association (ALA) has awarded $50,000 for a project aimed at regenerating damaged lung tissue. Researcher Ya-Wen Chen, PhD, hopes her project will ultimately help to improve lung function in people with conditions such as chronic obstructive pulmonary disease…
The U.S. Food and Drug Administration (FDA) has granted Organicell Regenerative Medicine permission to begin a clinical trial testing the company’s lead product, Zofin, in people with chronic obstructive pulmonary disease (COPD). The approved trial design will be a double-blinded, placebo-controlled, phase 1/2 trial to assess the…
In a pilot Phase 2 study, inhaled hyaluronan — which uses sugar secreted by living tissue that acts as a scaffold for cells — treated people with acute exacerbations of chronic obstructive pulmonary disease (COPD). The therapy was found to improve lung function, ease respiratory failure, and…
The nonprofit teaching hospital Holy Cross Health has partnered with the COPD Foundation to open a pilot program to help people with chronic obstructive pulmonary disease (COPD) and related lung disorders in managing their health at their homes. Funded by Herb Yardley, a member of the foundation’s board…
A new, noninvasive breath biopsy panel — dubbed “a Breathalyzer for disease” — can distinguish several airway disorders, including chronic obstructive pulmonary disease (COPD), its developer said. Launched by Owlstone Medical, the panel may help in diagnosing COPD. The tool, officially called the Respiratory Diseases Research Use Only (RUO)…
A pilot study on the first wireless nebulizer for use by people with chronic obstructive pulmonary disease (COPD) has been cleared by a review board of the U.S. Food and Drug Administration (FDA), Wellinks, the nebulizer’s developer, announced. “Getting into the field with our first digital health offering…
In people with chronic obstructive pulmonary disease (COPD) who experience acute exacerbations, the use of amoxicillin alone is associated with better outcomes than treatment with amoxicillin in combination with clavulanic acid, another antibiotic, a Danish study shows. The study, “Antibiotic treatment in acute exacerbation of COPD:…
Noninvasive ventilation at home, known as NIVH, is associated with a significantly lower risk of death, hospitalization, and emergency room (ER) visits among chronic obstructive pulmonary disease (COPD) patients with chronic respiratory failure, according to a study based on Medicare data. Notably, the NIVH-associated reduced risk of hospitalization was…
People in China with chronic obstructive pulmonary disease (COPD) are overusing inhaled corticosteroids and underusing non-pharmacological therapies such as home oxygen therapy, a study suggests. The real-world data show that treatment of COPD patients fails to follow the 2017 revised Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines.
Recent Posts
- From bird lice to COPD sensations, the body always tells the truth
- We should practice being calm for the moments when we are not
- After a missed Easter, I resolve not to let other holidays slip by unnoticed
- The value of tapping into COPD community resources
- Tozorakimab reduces COPD exacerbations in two large clinical trials